RE
RMD icon

RBC Europe’s ResMed RMD Stock Holding History

RBC Europe’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-65
Closed -$17.1K – 1037
2021
Q3 		$17.1K Buy
65
+25
+63% +$6.84K ﹤0.01% 828
2021
Q2 		$9.86K Hold
40
– – ﹤0.01% 956
2021
Q1 		$7.76K Sell
40
-85
-68% -$17K ﹤0.01% 948
2020
Q4 		$26.6K Hold
125
– – ﹤0.01% 648
2020
Q3 		$21.4K Sell
125
-30
-19% -$5.54K ﹤0.01% 632
2020
Q2 		$29.8K Hold
155
– – ﹤0.01% 549
2020
Q1 		$22.8K Buy
+155
New +$24.7K ﹤0.01% 531
2019
Q1 		– Sell
-324
Closed -$36.9K – 1100
2018
Q4 		$36.9K Hold
324
– – ﹤0.01% 502
2018
Q3 		$37.4K Hold
324
– – ﹤0.01% 545
2018
Q2 		$33.6K Hold
324
– – ﹤0.01% 558
2018
Q1 		$31.9K Sell
324
-154
-32% -$14.6K ﹤0.01% 572
2017
Q4 		$40.5K Hold
478
– – 0.01% 523
2017
Q3 		$36.8K Buy
+478
New +$36.6K ﹤0.01% 542

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
OCBV
Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

RBC Europe's RMD Position: Q4 2021 in Review

RBC Europe sold out of ResMed (RMD) in Q4 2021, closing a stake of 65 shares — an estimated $17.1K sold.

RBC Europe first reported a position in RMD in Q3 2017 and held it in 13 quarters. The position peaked at $40.5K in Q4 2017. 723 funds tracked by Wall St. Rank hold RMD as of Q4 2021.

  • RBC Europe reported no remaining ResMed position as of Q4 2021 after selling out during the quarter.
  • RBC Europe sold 65 ResMed shares in Q4 2021, an estimated $17.1K.
  • RBC Europe first reported a position in ResMed in Q3 2017 and held it in 13 quarters.
  • RBC Europe's ResMed position peaked at $40.5K in Q4 2017.
  • 723 funds tracked by Wall St. Rank held ResMed as of Q4 2021.

Based on RBC Europe's 13F filing for Q4 2021, filed 14 Nov 2022.